Mindfulness Practice vs Strength Training on Pain, Kinesiophobia and Function Among Sprinters
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 28, 2024
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how two different approaches—mindfulness practice and strength training—affect pain, fear of movement (called kinesiophobia), and overall function in sprinters who have a specific knee condition known as patellofemoral pain syndrome. Participants will be divided into two groups: one will only do strength training, while the other will combine strength training with mindfulness exercises, which help with relaxation and focus. The goal is to see which method is more effective in helping sprinters manage their pain and improve their ability to move without fear.
To be eligible for this study, participants need to be adults aged 18 to 40 who run at least twice a week for over 45 minutes or cover a minimum of 10 kilometers weekly. They should have been experiencing knee pain related to running for at least three months, without any recent injuries. However, those with certain knee conditions or previous knee surgeries cannot participate. If you join the trial, you'll be monitored closely and receive guidance on the exercises, helping you potentially improve your knee health and running performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and Female between the ages of 18 and 40 years, Report running ≥2 times per week for \>45 minutes or a minimum weekly running distance of 10 km, Present a history of insidious onset of signs and symptoms of PFP in 1 or both knees that was unrelated to trauma for at least 3 months before assessment, score \<85/100 on the Activities of Daily Living Scale and Sports related of the Knee Outcome Survey (KOS-ADLS)
- Exclusion Criteria:
- • Intra-articular condition, Coexisting lower limb injury, History of patellar dislocation or knee surgery, Osgood-Schlatter or Sinding- Larsen-Johansson syndrome
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Sana Malik, DPT
Principal Investigator
Study Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported